ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 7 analysts with an average price target of $59.91. This is a potential upside of $52.11 (668.08%) from yesterday's end of day stock price of $7.8.

Atara Biotherapeutics's activity chart (see below) currently has 68 price targets and 77 ratings on display. The stock rating distribution of ATRA is 50% BUY, 15% SELL and 35% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.92% with an average time for these price targets to be met of 68.9 days.

Highest price target for ATRA is $25, Lowest price target is $10, average price target is $21.75.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 11-Mar-2025. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 10 are a BUY (50%), 3 are a SELL (15%), 7 are a HOLD (35%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$9.2 (117.95%)

$17

2 months 21 days ago
(11-Mar-2025)

2/6 (33.33%)

$10.39 (157.19%)

59

Hold

4 months 4 days ago
(28-Jan-2025)

1/4 (25%)

$376.5 (88.90%)

175

Hold

$10

$2.2 (28.21%)

$125

6 months 19 days ago
(13-Nov-2024)

2/6 (33.33%)

$-4.26 (-29.87%)

33

Buy

$25

$17.2 (220.51%)

9 months 16 days ago
(16-Aug-2024)

0/4 (0%)

$17.99 (256.63%)

Sell

$35

$27.2 (348.72%)

$75

1 years 9 months 11 days ago
(21-Aug-2023)

13/13 (100%)

$-0.25 (-0.71%)

298

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 68.9 days on average for the stock forecasts to be realized with a an average price target met ratio 37.92

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $617.2

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Salveen Richter with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?